Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation

Giuseppe De Placido, Salvatore Conforti(Centro Medicina della Riproduzione), Ida Strina(University of Naples Federico II), Martin Wilding, Antonio Borrelli(University of Naples Federico II), Antonio Mollo(Northwestern University), Erminia Alviggi(Centro Medicina della Riproduzione), Carlo Alviggi(University of Naples Federico II), Antonio Ranieri, Maria Teresa Varricchio
Clinical Endocrinology
April 22, 2004
10.1111/j.1365-2265.2004.02027.x
Cited by 82

Related Papers

The management of Asherman syndrome: a review of literature
|Reproductive Biology and Endocrinology|2013|263
Hysteroscopic resection of the septum improves the pregnancy rate of women with unexplained infertility: a prospective controlled trial
|Fertility and Sterility|2008|247
Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial
|Human Reproduction|2004|178
Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study
|Journal of Minimally Invasive Gynecology|2018|150
Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review
|Fertility and Sterility|2018|144